newsfilter
← Latest News
GlobeNewswire·

AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan

IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin complex for